SSRI - Paxil etc)
"Paxil" antidepressant tablets (manufactured and distributed by GlaxoSmithKline K.K.) are a type of SSRI (selective serotonin reuptake inhibitor) which came out on the market in November 2000 in Japan.
It is now widely used as an antidepressant, and was the top-earning antidepressant in the Japanese market (50 billion yen) in 2007.
Our activities are as follows:
Oct.2004
Submission of written requests to the Ministry of Health, Labour and Welfare and companies, asking to disclose information of suicide risk concerning SSRI
Nov.2004
Held a symposium (speaker: Charles Medawar)
Dec.2006
Held a symposium (speaker: David Healy)
May.2008
Submission of request letters regarding violence issues to,
the companies (request revisions of the package insert),
the Ministry of Justice (request a survey）,
the Ministry of Health, Labour and Welfare (request a survey）,
the Japan Federation of Bar Associations (request a survey）
Jul.2009
Submission of an open question "Demand for Publication of Information Related to Post-Marketing Clinical Trials on Children and Adolescents Using the Antidepressant Paxil" to GSK and the Ministry of Health, Labour and Welfare (the MHLW).
Oct.2009
Based on the above observations, we have strong doubts over the legitimacy of conducting this pediatric study, and submit a request letter entitled "Revision of Package Insert and Need of information leaflet or Patient on Antidepressant Paxil Tablets in Pregnant Women" to GSK and the MHLW．
June.2010
Held a symposium (speaker: David Healy, Derelie Mangin)
Topics
- YAKUGAI Ombudsperson
- Tie-up Group
- 2010-06-05
- Symposium" Drug Safety and Drug Companies Marketing" June 5th, 2010 (Guest speakers: David Healy, Derelie Mangin)
- 2006-12-03
- 10th Memorial Symposium of HIV Litigation Settlement December 3, 2006 (Guest speaker: David Healy)
- 2004-11-23
- Seminar "Medicines Out Of Control" November 23, 2004 (Guest speaker: Charles Medawar)
